meddevicedb.com FDA Device Reference

FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)

K210943 Class II Traditional
Decision Date
2021-11-22
Sponsor / Applicant
Abbott Diabetes Care, Inc.

Technical Specification

510(k) Submission ID K210943
Product Code QLG
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1355
Decision Date 2021-11-22
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App) received FDA 510(k) clearance under submission number K210943, sponsored by Abbott Diabetes Care, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2021-11-22.

Classification & Regulation

This clearance is catalogued under FDA product code QLG and 21 CFR 862.1355, within the Clinical Chemistry review panel as a Class II device.